HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Indoco Remedies gets warning letter for Goa facility
Dec-17-2024

Indoco Remedies has received a warning letter from the US Food and Drug Administration (USFDA) for Plant II & Plant III facility located at Verna Industrial Estate Area, Verna, Goa, India (Facility) on December 17, 2024. This facility was inspected from July 16, 2024 to July 26, 2024. The Company remains committed to work closely with the USFDA and continues to enhance its compliance on an ongoing basis.

Earlier, the company had received Official Action Indicated (OAI) status from the USFDA for said facility. 

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

  RELATED NEWS >>